Insulin and Endometrial Cancer Risk
Author Information
Author(s): Weiderpass E, Brismar K, Bellocco R, Vainio H, Kaaks R
Primary Institution: International Agency for Research on Cancer
Hypothesis
What is the relationship between serum levels of insulin-like growth factor-I, IGF-binding proteins, insulin, and the risk of endometrial cancer?
Conclusion
The study found no overall association between endometrial cancer risk and serum levels of IGF-1, IGFBP-1, IGFBP-3, and insulin.
Supporting Evidence
- Obesity is associated with a 2-to-5-fold increase in endometrial cancer risk.
- Insulin resistance and type II diabetes are established risk factors for endometrial cancer.
- Women with elevated fasting serum levels of C-peptide have an increased risk of endometrial cancer.
Takeaway
This study looked at whether certain hormones in the blood could affect the risk of getting endometrial cancer, and it found that they don't seem to be related.
Methodology
A population-based case-control study was conducted with women aged 50-74 years, assessing serum levels of fasting insulin, IGF-I, IGFBP-1, and IGFBP-3.
Potential Biases
Possible selection bias due to differences in blood collection methods and non-participation rates.
Limitations
The study may have selection bias and potential confounding factors related to hormone levels.
Participant Demographics
Women aged 50-74 years from 12 Swedish counties, with no prior hysterectomy or history of cancer.
Statistical Information
P-Value
0.0430
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website